Patents by Inventor Kenneth Walder

Kenneth Walder has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods and Compositions for Modulating Satiety
    Publication number: 20070281986
    Abstract: The present invention relates generally to a method for modulating the sensation of satiety perception and to agents useful for same. More particularly, the present invention identifies molecules which interact with ion channels thereby modulating the perception of satiety. The present invention contemplates, therefore, a method for modulating gastric distension by the administration of agents which control the activation or inhibition of mechanoreceptors. The present invention further provides compositions comprising these agents and methods of treatment using same. In a particular embodiment, the present invention permits modulation of the sensation of gastric distension by the administration of agents which control the activation of mechanoreceptors associated with mechanical stretch.
    Type: Application
    Filed: February 1, 2005
    Publication date: December 6, 2007
    Inventors: Gregory Collier, Kenneth Walder
  • Novel genes and their use in the modulation of obesity, diabetes and energy imbalance
    Publication number: 20070032642
    Abstract: The present invention relates generally to nucleic acid molecules encoding proteins associated with the modulation of obesity, diabetes and/or metabolic energy levels. More particularly, the present invention is directed to nucleic acid molecules and the recombinant and purified proteins encoded thereby and their use in therapeutic and diagnostic protocols for conditions such as obesity, diabetes and energy imbalance. The subject nucleic acid molecules and proteins and their derivatives, homologs, analogs, chemical equivalents and mimetics are proposed as therapeutic and diagnostic agents for obesity, diabetes and energy imbalance.
    Type: Application
    Filed: October 6, 2006
    Publication date: February 8, 2007
    Inventors: Gregory Collier, Paul Zimmet, Kenneth Walder, Kelly Windmill, Janine McMillan
  • Novel genes and their use in the modulation of obesity, diabetes and energy imbalance
    Publication number: 20060155111
    Abstract: The present invention relates generally to nucleic acid molecules encoding proteins associated with the modulation of obesity, diabetes and/or metabolic energy levels. More particularly, the present invention is directed to nucleic acid molecules and the recombinant and purified proteins encoded thereby and their use in therapeutic and diagnostic protocols for conditions such as obesity, diabetes and energy imbalance. The subject nucleic acid molecules and proteins and their derivatives, homologs, analogs, chemical equivalents and mimetics are proposed as therapeutic and diagnostic agents for obesity, diabetes and energy imbalance.
    Type: Application
    Filed: December 31, 2001
    Publication date: July 13, 2006
    Applicant: AUTOGEN RESEARCH PTY LTD.
    Inventors: Gregory Collier, Paul Zimmet, Kenneth Walder, Kelly Windmill, Janine McMillan